DBVT
Price
$0.58
Change
+$0.02 (+3.57%)
Updated
Nov 15, 03:13 PM (EDT)
PIRS
Price
$15.85
Change
-$0.10 (-0.63%)
Updated
Nov 15, 03:13 PM (EDT)
Ad is loading...

DBVT vs PIRS

Header iconDBVT vs PIRS Comparison
Open Charts DBVT vs PIRSBanner chart's image
DBV Technologies SA
Price$0.58
Change+$0.02 (+3.57%)
Volume$124
CapitalizationN/A
Pieris Pharmaceuticals
Price$15.85
Change-$0.10 (-0.63%)
Volume$994
CapitalizationN/A
DBVT vs PIRS Comparison Chart
Loading...
DBVT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PIRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
DBVT vs. PIRS commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBVT is a Hold and PIRS is a StrongBuy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (DBVT: $0.56 vs. PIRS: $15.95)
Brand notoriety: DBVT and PIRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DBVT: 4% vs. PIRS: 497%
Market capitalization -- DBVT: $67.1M vs. PIRS: $21.12M
DBVT [@Biotechnology] is valued at $67.1M. PIRS’s [@Biotechnology] market capitalization is $21.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBVT’s FA Score shows that 0 FA rating(s) are green whilePIRS’s FA Score has 1 green FA rating(s).

  • DBVT’s FA Score: 0 green, 5 red.
  • PIRS’s FA Score: 1 green, 4 red.
According to our system of comparison, PIRS is a better buy in the long-term than DBVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DBVT’s TA Score shows that 3 TA indicator(s) are bullish while PIRS’s TA Score has 3 bullish TA indicator(s).

  • DBVT’s TA Score: 3 bullish, 5 bearish.
  • PIRS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both DBVT and PIRS are a bad buy in the short-term.

Price Growth

DBVT (@Biotechnology) experienced а -24.24% price change this week, while PIRS (@Biotechnology) price change was -3.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

DBVT is expected to report earnings on Jul 29, 2024.

PIRS is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DBVT($67.1M) has a higher market cap than PIRS($21.1M). PIRS YTD gains are higher at: 9.547 vs. DBVT (-70.613). PIRS has more cash in the bank: 89.9M vs. DBVT (15.7M). PIRS has less debt than DBVT: PIRS (0) vs DBVT (7.24M).
DBVTPIRSDBVT / PIRS
Capitalization67.1M21.1M318%
EBITDAN/AN/A-
Gain YTD-70.6139.547-740%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash15.7M89.9M17%
Total Debt7.24M0-
FUNDAMENTALS RATINGS
DBVT vs PIRS: Fundamental Ratings
DBVT
PIRS
OUTLOOK RATING
1..100
521
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
9050
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PIRS's Valuation (20) in the Biotechnology industry is in the same range as DBVT (38). This means that PIRS’s stock grew similarly to DBVT’s over the last 12 months.

PIRS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DBVT (100). This means that PIRS’s stock grew similarly to DBVT’s over the last 12 months.

DBVT's SMR Rating (97) in the Biotechnology industry is in the same range as PIRS (98). This means that DBVT’s stock grew similarly to PIRS’s over the last 12 months.

PIRS's Price Growth Rating (50) in the Biotechnology industry is somewhat better than the same rating for DBVT (90). This means that PIRS’s stock grew somewhat faster than DBVT’s over the last 12 months.

PIRS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as DBVT (100). This means that PIRS’s stock grew similarly to DBVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DBVTPIRS
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
DBVT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PIRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

DBVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, DBVT has been closely correlated with PIRS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if DBVT jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
-9.68%
PIRS - DBVT
78%
Closely correlated
-0.93%
WINT - DBVT
78%
Closely correlated
-6.25%
NCNA - DBVT
77%
Closely correlated
-1.90%
CDTX - DBVT
77%
Closely correlated
+4.17%
SNPX - DBVT
75%
Closely correlated
-4.68%
More

PIRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PIRS has been closely correlated with CDTX. These tickers have moved in lockstep 96% of the time. This A.I.-generated data suggests there is a high statistical probability that if PIRS jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PIRS
1D Price
Change %
PIRS100%
-0.93%
CDTX - PIRS
96%
Closely correlated
+4.17%
NCNA - PIRS
95%
Closely correlated
-1.90%
NBY - PIRS
95%
Closely correlated
+2.04%
SNPX - PIRS
94%
Closely correlated
-4.68%
RNAC - PIRS
94%
Closely correlated
-0.58%
More